Search research articles
Contact Us
Filters
Showing results (391-400 of 498) with videos related to
Page
of 50
Sort By:
International Journal of Surgical Pathology
|
October 17, 2022
Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms
Rahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup
David P Labbé, Christopher J Sweeney, Myles Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
European Urology Oncology
|
July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial
Ryan M Phillips, James A Proudfoot, Elai Davicioni, et al.
European Urology
|
October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial
Todd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
European Urology
|
December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer
Kosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C Jackson, Jessica Silva, Holly E Hartman, et al.
Page
of 50
Search research articles
Search
Showing results (391-400 of 498) with videos related to
Sort By:
Page
of 50
International Journal of Surgical Pathology
|
October 17, 2022
Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms
Rahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup
David P Labbé, Christopher J Sweeney, Myles Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
European Urology Oncology
|
July 17, 2025
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial
Ryan M Phillips, James A Proudfoot, Elai Davicioni, et al.
European Urology
|
October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial
Todd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Cancer
|
December 20, 2025
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
Daniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
European Urology
|
December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer
Kosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C Jackson, Jessica Silva, Holly E Hartman, et al.
Page
of 50